{"id":768,"date":"2025-01-22T13:04:32","date_gmt":"2025-01-22T13:04:32","guid":{"rendered":"https:\/\/www.nordicbioscience.com\/?post_type=biomarker-solutions&p=768"},"modified":"2025-06-06T08:58:03","modified_gmt":"2025-06-06T08:58:03","slug":"enhanced-liver-fibrosis-elf-test","status":"publish","type":"biomarker-solution","link":"https:\/\/www.nordicbioscience.com\/biomarker-solution\/hepatic\/enhanced-liver-fibrosis-elf-test\/","title":{"rendered":"Enhanced Liver Fibrosis (ELF) Test"},"content":{"rendered":"
\n \n
\n
\n
\n
\n

ELF\u2122 is a non-invasive test to assess fibrosis in liver and metabolic diseases<\/h2>\n \n\n <\/div>\n
\n
\n

The ELF score<\/strong><\/h3>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n

The ELF score has been well-validated against biopsy-proven fibrosis across a range of chronic liver diseases (CLD) in both adult and pediatric populations.\u00a0The three direct markers of the ELF test provide complementary information, and the combined score outperforms both the individual markers and simple scores such as APRI or FIB-4.\u200b<\/p>\n

The performance of the ELF test for liver fibrosis has been well-established in the scientific literature, and ease of testing and interpretation support routine clinical use as an alternative to invasive biopsy.\u200b<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n <\/div>\n

\n

Publications<\/h3>\n